Cardiovascular Stents Market Exhibits 6.6% CAGR, Market to Gain from Introduction of Bio-Stents Forecast by 2025, says Fortune Business Insights

Pune, India, April, 2019: Medtronic, Abbott, and Boston Scientific Corporation are currently holding the dominant share in the Global Cardiovascular Stents Market. However, as per Fortune Business Insights, Abbott is expected to lose its control over the market in India owing to the withdrawal of its foremost XEINCE alpine stent from the Indian cardiovascular stent market. This could create challenge for Abbott’s, making it difficult for it to maintain a stronghold.

As Abbot’s grip is loosened over the market, other market players such as Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cardinal Health, and Terumo Corporation are making constant efforts to consolidate a larger customer base, subsequently strengthen their foothold in the global cardiovascular stents market. According to a report published by Fortune Business Insights, titled “Cardiovascular Stent Market: Global Market Analysis, Insights and Forecast, 2018-2025,” The market is anticipated to reach US$ 13,100.2 Mn by the end of 2025 from US$ 7,838.9 Mn in 2017, with a promising CAGR of 6.6% between 2018 and 2025.”

Development of the next generation drugs for drug eluting stents (DES) has catapulted it to the fore of the global cardiovascular stent market. This will lead to DES being the dominant leader among segments.

Rapid Adoption of Sedentary Lifestyle may Spur Incidence of Chronic Ailments, fueling Demand for Coronary Procedure

The rising incidence of cardiovascular diseases globally is one of the chief drivers enabling growth in the global cardiovascular stents market. Unhealthy lifestyle adopted by people around the world y has stoked the prevalence of diseases such as atherosclerosis and obesity. Constantly increasing incidence of cardiovascular diseases has fueled the demand for treatments such as angioplasty. Additionally, introduction of new stents with advanced functions by various developers across the globe has bode well for the global cardiovascular stents market.

Coronary stenting was the most used treatment in 2017. It held 66.9% of the global cardiovascular stents market. “Increasing investment by market players in research and development of decomposable and environmental friendly coronary stents is expected to generate high demand for the coronary procedure,” said a lead analyst at Fortune Business Insights.

Among the end users, hospitals recorded the highest consumption of cardiovascular stents. Hospitals are expected to be the major revenue generating segment among end users by the end of forecast period. Against this backdrop, Fortune Business Insights predicts that increasing availability of highly qualified and trained doctors across hospitals will bode well for the overall market.

owing North America, trailed by Asia Pacific to Emerge Dominant

North America emerged dominant in the global cardiovascular stents market in 2017. The North America cardiovascular stents market was valued at US$ 2,334.9 Mn in 2017 and is expected to grow over the forecast period at a significant CAGR. Ongoing clinical trials on new stents and presence of several new technologies awaiting approval from regulatory authorities are projected to enable the cardiovascular stents market grow at an accelerated pace in North America.

Following North America, Asia Pacific offered lucrative growth prospects to the cardiovascular stents market. Countries such as India is undertaking price capping of stents to make the stents more accessible across the country. This is expected to fuel the demand for cardiovascular stents in the region. Besides this, constant effort by manufacturers in countries such as China and Australia to improve the stents distribution system is anticipated to fuel the growth rate of the cardiovascular stents market in Asia Pacific.

Fortune Business Insight’s report also provides an insightful overview of opportunities, strategies used by the leading organization in the market, and the potential areas of development.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/cardiovascular-stents-market-100061

The global Cardiovascular Stents market can be segmented into the following categories: 

• Global Cardiovascular Stents Market, by Procedure Type
  • Coronary Stenting
  • Peripheral Stenting
• Global Cardiovascular Stents Market, by Stent Type
  • Drug Eluting Stents (DES)
  • Bioresorbable Stents
  • Bare Metal Stents
  • Others
• Global Cardiovascular Stents Market, by Disease Indication
  • Venous Diseases
  • Arterial Diseases
• Global Cardiovascular Stents Market, by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Catheterization Labs
• Global Cardiovascular Stents Market, by Region
  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa